PRK Partners is a leading regional full-service law firm with a team of experienced legal and tax professionals and close to thirty years’ experience in providing outstanding service in Central Europe. The firm has worked on many of the region’s largest and most complex transactions. With offices and teams in both the Czech Republic and Slovakia PRK is perfectly suited for cross-border matters between these two countries. PRK combines profound knowledge of the local legal system with an international perspective. The firm frequently works on a non-exclusive basis with leading international law firms on large cross-border transactions.
PRK’s team is led by highly experienced and internationally educated partners. The team includes eminent academics who have co-authored key legislation in the Czech Republic and Slovakia.
PRK is consistently recognised among the top law firms by leading international and domestic directories and rating agencies and has been honoured with numerous awards, repeatedly Best Law Firm of the Year (national competitions organized by epravo.cz), Law Firm of the Year 2016 by Chambers & Partners, Law Firm of the Year 2012 for the Central European Region (and consistently ranked among the top 6 finalists every year) by top UK legal magazine, The Lawyer.
We are especially honored to receive the special 2020 Best Pro Bono/CSR Law Firm of the Year award. The firm has a strong commitment to corporate social responsibility and pro bono work.
PRK Partners is the exclusive member firm in the Czech Republic for Lex Mundi, the world’s leading network of independent law firms, with in-depth experience in 100+ countries worldwide. The firm is also a member of the Celia Alliance, AFI (Association for Foreign Investment) and CVCA (the Czech Private Equity and Venture Capital Association).
Key legal info on biosimilars & biologics in Czech Republic. Prepared in association with PRK Partners, a leading law firm in Czech Republic, this is an extract from The Pharma Legal Handbook: Czech Republic, available to purchase here for GBP 99. 1. Are biosimilar medicines considered the same as generic medicines in your country? No, biosimilars are not regarded as generics of biological medicines. Czech legislation implements EU directives, and directly applicable EU regulations on biosimilars and biologics apply. EU…
Want to know more about localization in Czech Republic? Prepared in association with PRK Partners, a leading law firm in Czech Republic, this is an extract from The Pharma Legal Handbook: Czech Republic, available to purchase here for GBP 99. 1. Are there any rules or regulations requiring and/or encouraging localization in your country? What is the legal framework defining these localization rules and policies? As a general rule, there are no localization requirements relating to medicinal products in the…
An intro to the legal situation for orphan drugs and rare diseases in Czech Republic. Prepared in association with PRK Partners, a leading law firm in Czech Republic, this is an extract from The Pharma Legal Handbook: Czech Republic, available to purchase here for GBP 99. 1. What is the definition of Rare Diseases in your country? The relevant Czech regulation defines rare diseases as those with a very low incidence in the population, within the meaning of the relevant…